Funds holding NEUPHORIA THERAPEUTICS INC
6 funds declare a position · 1 ETFs and 5 other funds · 1.1M $ · US64136E1029
Each line carries its report date.
| Fund | Shares | Value | Weight | |
|---|---|---|---|---|
| AdvisorShares Psychedelics ETF AdvisorShares Trust | 155,367 | 632.3K $ | 3.12 % | as of Mar 31, 2026 · Original filing |
| VANGUARD EXTENDED MARKET INDEX FUND VANGUARD INDEX FUNDS | 63,534 | 258.6K $ | 0.00 % | as of Mar 31, 2026 · Original filing |
| VANGUARD TOTAL STOCK MARKET INDEX FUND VANGUARD INDEX FUNDS | 34,982 | 142.4K $ | as of Mar 31, 2026 · Original filing | |
| Fidelity Extended Market Index Fund Fidelity Concord Street Trust | 12,263 | 50.9K $ | 0.00 % | as of Feb 28, 2026 · Original filing |
| Fidelity Series Total Market Index Fund Fidelity Concord Street Trust | 2,336 | 9.7K $ | as of Feb 28, 2026 · Original filing | |
| Fidelity Total Market Index Fund Fidelity Concord Street Trust | 2,001 | 8.3K $ | as of Feb 28, 2026 · Original filing |
Institutional managers
19 managers declare this company to the SEC (Form 13F). These positions are not counted in the totals above: a manager and its own funds file separately.
| Manager | Shares | Value | |
|---|---|---|---|
| Lynx1 Capital Management LP | 875,328 | 3.6M $ | as of Mar 31, 2026 |
| AdvisorShares Investments LLC | 155,367 | 632.3K $ | as of Mar 31, 2026 |
| Shay Capital LLC | 151,010 | 614.6K $ | as of Mar 31, 2026 |
| Balyasny Asset Management L.P. | 142,183 | 578.7K $ | as of Mar 31, 2026 |
| VANGUARD CAPITAL MANAGEMENT LLC | 98,516 | 401K $ | as of Mar 31, 2026 |
| Squadron Capital Management LLC | 76,728 | 312.3K $ | as of Mar 31, 2026 |
| GEODE CAPITAL MANAGEMENT, LLC | 52,007 | 211.7K $ | as of Mar 31, 2026 |
| Ikarian Capital, LLC | 47,443 | 193.1K $ | as of Mar 31, 2026 |
| VANGUARD FIDUCIARY TRUST CO | 33,589 | 136.7K $ | as of Mar 31, 2026 |
| ADAR1 Capital Management, LLC | 30,000 | 122.1K $ | as of Mar 31, 2026 |
| CITADEL ADVISORS LLC | 19,331 | 78.7K $ | as of Mar 31, 2026 |
| BOOTHBAY FUND MANAGEMENT, LLC | 14,000 | 57K $ | as of Mar 31, 2026 |
| COMMONWEALTH EQUITY SERVICES, LLC | 11,222 | 45.7K $ | as of Mar 31, 2026 |
| Merck & Co., Inc. | 10,027 | 40.8K $ | as of Mar 31, 2026 |
| UBS Group AG | 2,316 | 9.4K $ | as of Mar 31, 2026 |
| RHUMBLINE ADVISERS | 202 | 822 $ | as of Mar 31, 2026 |
| MORGAN STANLEY | 58 | 236 $ | as of Mar 31, 2026 |
| FNY Investment Advisers, LLC | 26,500 | 107 $ | as of Mar 31, 2026 |
| Virtu Financial LLC | 12,033 | 49 $ | as of Mar 31, 2026 |